Pinto C.; Ardizzoni A.; Betta PG.; Facciolo F.; Tassi G.; Tonoli S.; Zompatori M.; Alessandrini G.; Magrini SM.; Tiseo M.; Mutri V, Expert opinions of the firts italian consensus conference on the management of malignant pleural mesothelioma, «AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS», 2011, 34, pp. 99 - 109 [articolo]
Postmus PE; Quoix E; Ardizzoni A; Garrido P; Le Chevalier T; Mehmud F; Fletcher JL, FIRST RESULTS OF THE PROSPECTIVE SCOT REGISTRY, «JOURNAL OF THORACIC ONCOLOGY», 2011, 6, pp. S1426 - S1427 [abstract]
Negri FV; Bozzetti C; Ardizzoni A; Lagrasta C; Crafa P; Silini EM, HER-2 discordance between primary gastric carcinoma and paired lymph node metastasis, «HUMAN PATHOLOGY», 2011, 42(6), pp. 909 - 910 [replica/breve intervento]
Gridelli C; Ardizzoni A; Barni S; Crinò L; Caprioli A; Piazza E; Lorusso V; Barbera S; Zilembo N; Gebbia V; Adamo V; Pela R; Marangolo M; Morena R; Filippelli G; Buscarino C; Alabiso O; Maione P; Venturino P; De Marinis F, Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational “SUN” (Survey on the Lung Cancer Management) study, «LUNG CANCER», 2011, 74(3), pp. 462 - 468 [replica/breve intervento]
Musolino A; Ciccolallo L; Panebianco M; Fontana E; Zanoni D; Bozzetti C; Michiara M; Silini EM; Ardizzoni A, Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study, «CANCER», 2011, 117, pp. 1837 - 1846 [replica/breve intervento]
Boggiani D; Musolino A; Panebianco M; Franciosi V; Vasini G; Salvagni S; Ardizzoni A, ACTIVITY AND SAFETY OF DOSE-ADJUSTED INFUSIONAL CHOP CHEMOTHERAPY WITH RITUXIMAB (DA-POCH-R) IN VERY ELDERLY PATIENTS WITH POOR-PROGNOSTIC UNTREATED DIFFUSE LARGE B-CELL NON-HODGKIN'S LYMPHOMA, «ANNALS OF ONCOLOGY», 2010, 21, pp. 352 - 352 [abstract]
GALETTI M; ALFIERI R.R; CAVAZZONI A; LA MONICA S; BONELLI M; FUMAROLA C; MOZZONI P; DE PALMA G; ANDREOLI R; MUTTI A; MOR M; TISEO M; ARDIZZONI A; PETRONINI P.G, Functional characterization of gefitinib uptake in non small cell lung cancer cell lines, «BIOCHEMICAL PHARMACOLOGY», 2010, 80, pp. 179 - 187 [replica/breve intervento]
Musolino A; Michiara M; Conti GM; Boggiani D; Bozzani F; Zatelli M; Sgargi P; Ardizzoni A, HER2 STATUS AS PREDICTOR OF MAMMOGRAPHIC SCREENING DETECTION: COMPARISON OF INTERVAL- AND SCREEN-DETECTED BREAST CANCERS, «ANNALS OF ONCOLOGY», 2010, 21, pp. 78 - 79 [replica/breve intervento]
Bozzetti C; Tiseo M; Lagrasta C; Nizzoli R; Guazzi A; Graiani G; Rindi G; Ardizzoni A, Is Cytology Reliable for Epidermal Growth Factor Receptor Gene Evaluation in Non-small Cell Lung Cancer?, «JOURNAL OF THORACIC ONCOLOGY», 2010, 5, pp. 551 - 553 [replica/breve intervento]
Gridelli C; Ardizzoni A; Bajetta E; Barni S; Crino L; Caprioli A; Filipazzi V; Lorusso V; De Marinis F, MEDICAL TREATMENT CHOICES OF PATIENTS AFFECTED BY ADVANCED NSCLC IN ROUTINE CLINICAL PRACTICE: RESULTS FROM THE ITALIAN OBSERVATIONAL "SUN'' (SURVEY ON THE LUNG CANCER MANAGEMENT) STUDY, «ANNALS OF ONCOLOGY», 2010, 21, pp. 151 - 151 [abstract]
Carmi C.; Cavazzoni A.; Vezzosi S.; Bordi F.; Vacondio F.; Silva C.; Rivara S.; Lodola A.; Alfieri R.; Monica S. La; Galetti M.; Ardizzoni A.; Petronini P.G.; Mor M., Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion, «JOURNAL OF MEDICINAL CHEMISTRY», 2010, 53, pp. 2038 - 2050 [replica/breve intervento]
Tiseo M; Rossi G; Capelletti M; Sartori G; Spiritelli E; Marchioni A; Bozzetti C; De Palma G; Lagrasta C; Campanini N; Camisa R; Boni L; Franciosi V; Rindi G; Ardizzoni A, Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): Study of a comprehensive panel of molecular markers, «LUNG CANCER», 2010, 67, pp. 355 - 360 [replica/breve intervento]
F.NEGRI; C. BOZZETTI; CA. LAGRASTA; P. CRAFA; MP. BONASONI; R. CAMISA; G. PEDRAZZI; ARDIZZONI A, PTEN status in advanced colorectal cancer treated with cetuximab, «BRITISH JOURNAL OF CANCER», 2010, 102, pp. 162 - 164 [replica/breve intervento]
Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F, Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology, «LUNG CANCER», 2010, 68, pp. 319 - 331 [replica/breve intervento]
Ardizzoni A; Boni L; Tiseo M; Marini L; Mehmud F, REFRACTORY VS SENSITIVE RELAPSED SCLC: VALIDATION OF STANDARD DEFINITION AND ASSESMENT OF ALTERNATIVE CLASSIFICATION, «ANNALS OF ONCOLOGY», 2010, 21, pp. 148 - 148 [abstract]
